Gipoksik-ishemik ensefalopatiya bilan yangi tug'ilgan chaqaloqlarni kompleks davolash

Hypoxic-ischemic encephalopathy is a serious brain disorder caused by oxygen and blood supply deficiency during the perinatal period, leading to neurological impairment and requiring timely diagnosis and treatment to prevent long-term disability. Study Objective. To evaluate the effectiveness of comprehensive treatment for newborns with hypoxic-ischemic encephalopathy of varying severity. Study Materials and Methods. The study included newborns treated in the neonatal pathology and neonatal intensive care units. A total of 80 newborns were observed and divided into two groups. The study group consisted of children (n = 40) who received combination therapy, including basic intensive care, antioxidant, and neurometabolic support. The comparison group (n = 40) received standard basic therapy according to protocols for the management of newborns with HIE. The severity of hypoxic-ischemic encephalopathy predicted treatment effectiveness: the best results were observed in children with grades I–II, whereas severe hypoxic-ischemic encephalopathy required a more individualized therapeutic approach.

Hali tarjima qilinmagan